Toward more transparent and reproducible omics studies through a common metadata checklist and data publications.
Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis.
Prioritizing disease-linked variants, genes, and pathways with an interactive whole-genome analysis pipeline.
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
